![Graham Johnson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham Johnson
Directeur/Membre du Conseil chez
Shimoda Resources Holdings Inc
Profil
Graham Johnson is currently a Director at Shimoda Resources Holdings, Inc. He previously worked as an Interim Vice President-Neuroscience Biology at Bristol Myers Squibb Co. and held the position of Senior VP-Preclinical Development & Research at Sarepta Therapeutics, Inc. from 2010 to 2011.
He also worked as a Principal at Parke-Davis & Co. Ltd. and as the Chief Research Officer at Melinta Subsidiary Corp.
Dr. Johnson received his undergraduate and doctorate degrees from Heriot-Watt University.
Postes actifs de Graham Johnson
| Sociétés | Poste | Début |
|---|---|---|
Shimoda Resources Holdings Inc
 Shimoda Resources Holdings Inc Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Directeur/Membre du Conseil | - |
Anciens postes connus de Graham Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 13/05/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Directeur Technique/Scientifique/R&D | - |
Formation de Graham Johnson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shimoda Resources Holdings Inc
Shimoda Resources Holdings Inc Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Heriot-Watt University
 Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
